Medivir AB took a first step toward building a commercial organization by entering a co-promotion agreement with London-based GlaxoSmithKline plc's Swedish subsidiary. The deal enables the company to market in Sweden a portfolio of dermatology and infectious disease products, as well as the smoking-cessation aid Zyban. (BioWorld International) Read More
